knowledge -WSS

knowledge

author：leisure time 2025-10-02 20:49:23 - browse：1

Doctor holding a clipboard. -- health coverage from STAT — Adobe

The momentum around weight loss drugs is about to get even bigger in the wake of Novo Nordisk’s announcement that its semaglutide drug Wegovy cut the risk of cardiovascular disease by 20% in its large SELECT trial.

The full results of the study, funded by Novo, will be presented at the American Heart Association meeting in November. Doctors and researchers say they expect the findings to have a big impact on how clinicians approach the treatment of both obesity and cardiovascular disease, as well as increase the likelihood that prescriptions for obesity drugs will be covered by insurance.

But experts who spoke with STAT also cautioned that the long-term safety and efficacy of Wegovy and other weight loss drugs remain unknown. The SELECT study has yet to be peer-reviewed, and not enough information is yet available to make independent assessments of the results.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Home health providers sue Medicare over payment cuts

WSS

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

Teachers share how revamped forgiveness program helped with their student loans

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

Researchers explore possible ties between long Covid, menopause

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

explore

knowledge

Wikipedia

Continuity nursing helped my family in our darkest PICU moments

Pandemic and All Hazards Preparedness Act needs lean update

Walensky prepares to leave CDC — and Congress — behind

Judge agrees to delay next hearing in Trump classified documents case

ChatGPT in medicine: STAT answers readers' burning questions

The U.S. needs a new definition of substance use “recovery”

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Eli Lilly expects to double planned employment in Boston center

The cancer drug shortage isn’t new — and neither are the solutions

NIH confirmation hearing shows politicization of research

Wikipedia

The U.S. needs a new definition of substance use “recovery”

Recent heat wave in the Mediterranean caused by climate change: Study

Impact of Dobbs ruling felt at reproductive medicine meeting

STAT Summit: GSK CEO on pharma giant's new direction

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

How climate

leisure time

knowledge

leisure time

entertainment